Symptom prevalence differences of depression as measured by BDI and PHQ scales in the Look AHEAD study.

Elizabeth M VaughanCraig A JohnstonJennette P MorenoLawrence J CheskinGareth R DuttonMolly GeeSarah A GaussoinWilliam C KnowlerJack W Rejeski Thomas A WaddenSusan Z YanovskiJohn P Foreytnull null

Published in: Obesity science & practice (2019)

Either the BDI-1A or PHQ-9 can be used to assess depressive symptomatology in adults with overweight/obesity and type 2 diabetes. However, further assessment should be considered in those with related somatic symptoms, decreased quality of life, and in racial/ethnic minority populations.

Keyphrases

type diabetes
weight loss
insulin resistance
weight gain
metabolic syndrome
sleep quality
risk factors
depressive symptoms
glycemic control
cardiovascular disease
bipolar disorder
copy number
stress induced
body mass index
high fat diet induced
gene expression